LCB01-0371

· LigaChem Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for LCB01-0371, covering 2014-11-17 to 2020-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK [Phase 2]